My Quote Request
No products added yet
6505-01-080-2380
20 Products
NDC62794-0002-51
TRYPSIN,BALSAM PERU,AND CASTOR OIL SOLUTION
NSN, MFG P/N
6505010802380
NSN
6505-01-080-2380
NDC62794-0002-51
TRYPSIN,BALSAM PERU,AND CASTOR OIL SOLUTION
NSN, MFG P/N
6505010802380
NSN
6505-01-080-2380
MFG
MYLAN BERTEK PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EACH 0.820 MILLILITER CONTAINS 72.500 MILLIGRAMS BALSAM PERU ACTIVE INGREDIENT AND 650.000 MILLIGRAMS CASTOR OIL ACTIVE INGREDIENT AND 0.100 MILLIGRAMS TRYPSIN ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRYPSIN BALSAM PERU AND CASTOR OIL SOLUTION AEROSOL CAN 4OZ
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HICKAM
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: CAN, AEROSOL
Related Searches:
56H4
ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION
NSN, MFG P/N
6505010802381
NSN
6505-01-080-2381
56H4
ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION
NSN, MFG P/N
6505010802381
NSN
6505-01-080-2381
MFG
WAMPOLE LABORATORIES DIV OF CARTER-WALLACE INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V HYDROCORTISONE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, V/V ACETIC ACID, GLACIAL ACTIVE INGREDIENT AND 0.020 PERCENTAGE, W/V BENZETHONIUM CHLORIDE ACTIVE INGREDIENT AND 0.015 PERCENTAGE, W/V SODIUM ACETATE ACTIVE INGREDIENT AND 0.200
ADMINISTRATION: OTIC
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC
~1: PERCENTAGE, W/V CITRIC ACID ACTIVE INGREDIENT AND 3.000 PERCENTAGE; V/V PROPYLENE GLYCOL DIACETATE ACTIVE INGREDIENT
Related Searches:
NDC0037-3811-12
ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION
NSN, MFG P/N
6505010802381
NSN
6505-01-080-2381
NDC0037-3811-12
ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION
NSN, MFG P/N
6505010802381
NSN
6505-01-080-2381
MFG
WAMPOLE LABORATORIES DIV OF CARTER-WALLACE INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V HYDROCORTISONE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, V/V ACETIC ACID, GLACIAL ACTIVE INGREDIENT AND 0.020 PERCENTAGE, W/V BENZETHONIUM CHLORIDE ACTIVE INGREDIENT AND 0.015 PERCENTAGE, W/V SODIUM ACETATE ACTIVE INGREDIENT AND 0.200
ADMINISTRATION: OTIC
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC
~1: PERCENTAGE, W/V CITRIC ACID ACTIVE INGREDIENT AND 3.000 PERCENTAGE; V/V PROPYLENE GLYCOL DIACETATE ACTIVE INGREDIENT
Related Searches:
VOSOL HC OTIC
ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION
NSN, MFG P/N
6505010802381
NSN
6505-01-080-2381
VOSOL HC OTIC
ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION
NSN, MFG P/N
6505010802381
NSN
6505-01-080-2381
MFG
WAMPOLE LABORATORIES DIV OF CARTER-WALLACE INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V HYDROCORTISONE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, V/V ACETIC ACID, GLACIAL ACTIVE INGREDIENT AND 0.020 PERCENTAGE, W/V BENZETHONIUM CHLORIDE ACTIVE INGREDIENT AND 0.015 PERCENTAGE, W/V SODIUM ACETATE ACTIVE INGREDIENT AND 0.200
ADMINISTRATION: OTIC
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC
~1: PERCENTAGE, W/V CITRIC ACID ACTIVE INGREDIENT AND 3.000 PERCENTAGE; V/V PROPYLENE GLYCOL DIACETATE ACTIVE INGREDIENT
Related Searches:
NDC00091-0690-10
HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE TOPICAL FOAM
NSN, MFG P/N
6505010802904
NSN
6505-01-080-2904
NDC00091-0690-10
HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE TOPICAL FOAM
NSN, MFG P/N
6505010802904
NSN
6505-01-080-2904
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V HYDROCORTISONE ACETATE ACTIVE INGREDIENT AND 1.000 PERCENTAGE, W/V PRAMOXINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: RECTAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE FOAM 10GM
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 GRAMS
PRIMARY CONTAINER TYPE: CAN, AEROSOL
SPECIAL FEATURES: W/APPLICATOR
Related Searches:
NDC00536-2145-19
HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE TOPICAL FOAM
NSN, MFG P/N
6505010802904
NSN
6505-01-080-2904
NDC00536-2145-19
HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE TOPICAL FOAM
NSN, MFG P/N
6505010802904
NSN
6505-01-080-2904
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V HYDROCORTISONE ACETATE ACTIVE INGREDIENT AND 1.000 PERCENTAGE, W/V PRAMOXINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: RECTAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE FOAM 10GM
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 GRAMS
PRIMARY CONTAINER TYPE: CAN, AEROSOL
SPECIAL FEATURES: W/APPLICATOR
Related Searches:
NDC00574-0002-11
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505010804111
NSN
6505-01-080-4111
NDC00574-0002-11
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505010804111
NSN
6505-01-080-4111
MFG
PADDOCK LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ASPIRIN DELAYED RELEASE TABLETS USP 325MG STRIP I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 PER PACKAGE
Related Searches:
NDC51079-0018-20
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505010804111
NSN
6505-01-080-4111
NDC51079-0018-20
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505010804111
NSN
6505-01-080-4111
MFG
UDL LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ASPIRIN DELAYED RELEASE TABLETS USP 325MG STRIP I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 PER PACKAGE
Related Searches:
8650
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505010805964
NSN
6505-01-080-5964
MFG
INVENEX LABORATORIES LIFE TECHNOLOGIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS INFUSION
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SINGLE DOSE VIAL
Related Searches:
NDC0467-0086-25
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505010805964
NSN
6505-01-080-5964
NDC0467-0086-25
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505010805964
NSN
6505-01-080-5964
MFG
INVENEX LABORATORIES LIFE TECHNOLOGIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS INFUSION
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SINGLE DOSE VIAL
Related Searches:
2B2584
DEXTROSE AND ELECTROLYTE INJECTION
NSN, MFG P/N
6505010805966
NSN
6505-01-080-5966
2B2584
DEXTROSE AND ELECTROLYTE INJECTION
NSN, MFG P/N
6505010805966
NSN
6505-01-080-5966
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 50.000 GRAMS DEXTROSE PER LITER AND 140.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 27 MEQ. ACETATE ION PER LITER AND 23 MEQ. GLUCONATE ION PER LITER AND 3 MEQ. MAGNESIUM ION PER LITER AND 5 MEQ.
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
~1: POTASSIUM ION PER LITER
Related Searches:
NDC00074-7968-09
DEXTROSE AND ELECTROLYTE INJECTION
NSN, MFG P/N
6505010805966
NSN
6505-01-080-5966
NDC00074-7968-09
DEXTROSE AND ELECTROLYTE INJECTION
NSN, MFG P/N
6505010805966
NSN
6505-01-080-5966
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 50.000 GRAMS DEXTROSE PER LITER AND 140.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 27 MEQ. ACETATE ION PER LITER AND 23 MEQ. GLUCONATE ION PER LITER AND 3 MEQ. MAGNESIUM ION PER LITER AND 5 MEQ.
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
~1: POTASSIUM ION PER LITER
Related Searches:
NDC00338-0149-04
DEXTROSE AND ELECTROLYTE INJECTION
NSN, MFG P/N
6505010805966
NSN
6505-01-080-5966
NDC00338-0149-04
DEXTROSE AND ELECTROLYTE INJECTION
NSN, MFG P/N
6505010805966
NSN
6505-01-080-5966
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 50.000 GRAMS DEXTROSE PER LITER AND 140.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 27 MEQ. ACETATE ION PER LITER AND 23 MEQ. GLUCONATE ION PER LITER AND 3 MEQ. MAGNESIUM ION PER LITER AND 5 MEQ.
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
~1: POTASSIUM ION PER LITER
Related Searches:
NORMOSOL-R LIFE CARE
DEXTROSE AND ELECTROLYTE INJECTION
NSN, MFG P/N
6505010805966
NSN
6505-01-080-5966
NORMOSOL-R LIFE CARE
DEXTROSE AND ELECTROLYTE INJECTION
NSN, MFG P/N
6505010805966
NSN
6505-01-080-5966
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 50.000 GRAMS DEXTROSE PER LITER AND 140.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 27 MEQ. ACETATE ION PER LITER AND 23 MEQ. GLUCONATE ION PER LITER AND 3 MEQ. MAGNESIUM ION PER LITER AND 5 MEQ.
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
~1: POTASSIUM ION PER LITER
Related Searches:
PLASMA-LYTE 148 VIAFLEX
DEXTROSE AND ELECTROLYTE INJECTION
NSN, MFG P/N
6505010805966
NSN
6505-01-080-5966
PLASMA-LYTE 148 VIAFLEX
DEXTROSE AND ELECTROLYTE INJECTION
NSN, MFG P/N
6505010805966
NSN
6505-01-080-5966
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 50.000 GRAMS DEXTROSE PER LITER AND 140.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 27 MEQ. ACETATE ION PER LITER AND 23 MEQ. GLUCONATE ION PER LITER AND 3 MEQ. MAGNESIUM ION PER LITER AND 5 MEQ.
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
~1: POTASSIUM ION PER LITER
Related Searches:
6365-02
ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP
NSN, MFG P/N
6505010809409
NSN
6505-01-080-9409
6365-02
ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP
NSN, MFG P/N
6505010809409
NSN
6505-01-080-9409
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHYSICAL FORM: CRYSTAL OR POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ALSO CONTAINS 90 MG. BENZYL ALCOHOL AS PRESERVATIVE; IN 20 ML. VIAL
Related Searches:
ERYTHROCIN
ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP
NSN, MFG P/N
6505010809409
NSN
6505-01-080-9409
ERYTHROCIN
ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP
NSN, MFG P/N
6505010809409
NSN
6505-01-080-9409
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHYSICAL FORM: CRYSTAL OR POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ALSO CONTAINS 90 MG. BENZYL ALCOHOL AS PRESERVATIVE; IN 20 ML. VIAL
Related Searches:
NDC00074-6365-02
ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP
NSN, MFG P/N
6505010809409
NSN
6505-01-080-9409
NDC00074-6365-02
ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP
NSN, MFG P/N
6505010809409
NSN
6505-01-080-9409
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHYSICAL FORM: CRYSTAL OR POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ALSO CONTAINS 90 MG. BENZYL ALCOHOL AS PRESERVATIVE; IN 20 ML. VIAL
Related Searches:
00025
PYRITHIONE ZINC SHAMPOO
NSN, MFG P/N
6505010809414
NSN
6505-01-080-9414
MFG
PROCTER & GAMBLE DISTRIBUTING COMPANY THE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE,W/W PYRITHIONE ZINC ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
HEAD & SHOULDERS
PYRITHIONE ZINC SHAMPOO
NSN, MFG P/N
6505010809414
NSN
6505-01-080-9414
HEAD & SHOULDERS
PYRITHIONE ZINC SHAMPOO
NSN, MFG P/N
6505010809414
NSN
6505-01-080-9414
MFG
PROCTER & GAMBLE DISTRIBUTING COMPANY THE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE,W/W PYRITHIONE ZINC ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
